Fig. 4. Percent of change in the proportion of gastroesophageal reflux disease patients using proton pump inhibitors between 2006 and 2016 using universal Explorys dataset (A) and Healthcare system dataset (B). *P < 0.001, **P < 0.05.
© J Neurogastroenterol Motil
